Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELX.L Regulatory News (ELX)

  • There is currently no data for ELX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Scheme of Reconstruction

2 Jul 2019 09:00

RNS Number : 1666E
El Oro Ltd
02 July 2019
 

2 July 2019

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA OR THE REPUBLIC OF SOUTH AFRICA

El Oro Ltd

Result of Scheme of Reconstruction

In relation to the recommended proposals for the voluntary winding-up and reconstruction of El Oro Ltd (the "Company") as set out in the circular published by the Company dated 24 May 2019 (the "Circular"), the Company announces the following.

Further to the approval of the resolutions to put the Company into voluntary liquidation which were proposed and duly passed on 20 June 2019, Nick Vermeulen and Christiaan Van Den Berg, both of PricewaterhouseCoopers CI LLP of Royal Bank Place, 1 Glategny Esplanade, St Peter Port, Guernsey, GY1 4ND have been appointed as liquidators.

Application has been made to the TISEA and the London Stock Exchange for the listing of the Reclassified Shares on the premium segment of the Official List and for trading on the SETSqx trading platform respectively to be cancelled at 7.00 a.m. on 22 July 2019.

Residual Value

On the Calculation Date the unaudited net asset value of the Company was £46,215,013.27 (calculated on a bid basis and providing for the estimated expenses of the winding up of the Company of £440,000, the value of the Illiquid Assets of £1,142,692.69 which will be retained in the Liquidation Fund and a retention for the Liquidation Fund of £500,000). On this basis, the Residual Value of an El Oro Share as at Thursday 27 June 2019 was £0.70959893 per Share.

Accordingly, and based on the elections and deemed elections, the aggregate value attributable to each of the Rollover Funds and to the Cash Option are as follows:

JPMorgan Elect Managed Growth Shares

£5,888,812.67

JPMorgan Elect Managed Income Shares

£19,480,689.52

JPMorgan Elect Managed Cash Shares

£805,188.04

Cash Option

£18,397,142.28

 Issue Prices

The JPMorgan Elect Issue Prices calculated as at 27 June 2019 were as follows:

JPMorgan Elect Managed Growth Shares (p)

870.92

JPMorgan Elect Managed Income Shares (p)

110.69

JPMorgan Elect Managed Cash Shares (p)

104.03

 

 

Settlement of Elections made by Shareholders will be as set out in the Circular with cheques expected to be despatched and CREST payments made to Shareholders in respect of the Cash Option on or as soon as practicable after 3 July 2019 and share certificates for JPMorgan Elect Securities issued under the Scheme expected to be despatched in the week commencing 15 July 2019.

 

 

Distributions from the Liquidation Fund

 

To the extent that any part of the Liquidation Fund is not required to meet the Company's liabilities or the liabilities of the UK Subsidiaries, including the net proceeds of sale of any of the Illiquid Assets, the balance remaining in the hands of the Liquidators will be paid as one or more liquidation distributions to Shareholders who are on the Company's register of members as at the close of business on the Scheme Effective Date on a pari passu basis pro rata to their respective holdings of Shares, provided that if any such amount otherwise payable to a Shareholder is less than £5.00, it will not be paid to such Shareholder but will be transferred by the Liquidators to a charity, Cancer Research UK (Registered Charity Number 1089464) (the Nominated Charity).

 

Shareholders will receive communication(s) from the Liquidators in due course.

Notes

Terms used and not defined in this announcement have the meanings given in the Circular unless the context otherwise requires.

 

For further information:

Liquidator:

Natalie Boes

natalie.boes@pwc.com

07911 163663

 

Nick Vermeulen

nick.vermeulen@pwc.com

01481 752000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLIFVDDIIFIIA
Date   Source Headline
7th Dec 20151:00 pmRNSDirector/PDMR Shareholding
20th Nov 20157:00 amRNSResult of EGM
20th Nov 20157:00 amRNSResult of AGM
10th Nov 20154:15 pmRNSNet Asset Value 30 October 2015
21st Oct 20154:30 pmRNSDirectors' Report 30 June 2015 - clarification
19th Oct 20158:45 amRNSTransaction in Own Shares
19th Oct 20158:45 amRNSDirector/PDMR Shareholding
15th Oct 201510:45 amRNSNet Asset Value(s)
30th Sep 201511:30 amRNSNet Asset Value(s) - Adjustment
29th Sep 20154:30 pmRNSDividend Declaration
29th Sep 20154:30 pmRNSAnnual Report & Accounts
10th Sep 201511:00 amRNSNet Asset Value 31 August 2015
24th Aug 20151:00 pmRNSNet Asset Value(s)
29th Jul 201510:30 amRNSNet Asset Value(s)
17th Jul 20159:00 amRNSDirector/PDMR Shareholding
8th Jun 20153:15 pmRNSNet Asset Value 31 May 2015
12th May 20151:00 pmRNSNet Asset Value - 30 April 2015
10th Apr 20159:00 amRNSNet Asset Value(s)
9th Apr 201512:00 pmRNSDirector/PDMR Shareholding
25th Mar 20157:00 amRNSDirector/PDMR Shareholding
23rd Mar 20152:30 pmRNSDirector/PDMR Shareholding
9th Mar 20153:15 pmRNSNet Asset Value - 27 February 2015
5th Mar 20153:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20154:00 pmRNSDirector/PDMR Shareholding
24th Feb 20152:30 pmRNSDirector/PDMR Shareholding
18th Feb 201512:00 pmRNSInterim Results
11th Feb 20153:15 pmRNSDirector/PDMR Shareholding
10th Feb 20153:30 pmRNSNet Asset Value 31 January 2015
12th Jan 20151:08 pmRNSNet Asset Value 31 December 2014
8th Dec 20142:33 pmRNSNet Asset Value 30 November 2014
27th Nov 20147:00 amRNSPerformance and asset allocation
20th Nov 20143:00 pmRNSResult of AGM
17th Nov 20144:02 pmRNSNet Asset Value 31 October 2014
14th Oct 201411:44 amRNSNet Asset Value(s)
13th Oct 20143:30 pmRNSTransaction in Own Shares
19th Sep 20143:15 pmRNSDividend Declaration
19th Sep 201410:45 amRNSAnnual Financial Report
19th Sep 20148:56 amRNSPreliminary Results
18th Sep 20144:30 pmRNSDividend Declaration
17th Sep 20142:16 pmRNSNet Asset Value(s)
26th Aug 20149:00 amRNSNet Asset Value(s)
18th Jul 201411:00 amRNSDirector/PDMR Shareholding
14th Jul 201411:00 amRNSNet Asset Value(s)
10th Jul 20143:30 pmRNSAIFMD appointment
2nd Jul 20142:23 pmRNSDirector/PDMR Shareholding
26th Jun 201412:26 pmRNSDirector/PDMR Shareholding
10th Jun 20142:41 pmRNSNet Asset Value 30 May 2014
4th Jun 20145:00 pmRNSDirector/PDMR Shareholding
29th May 20144:00 pmRNSDirector/PDMR Shareholding
15th May 201410:09 amRNSNet Asset Value - 30 April 2014

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.